100 related articles for article (PubMed ID: 9195165)
1. Allelic loss on chromosome 11 is uncommon in parathyroid glands of patients with hypercalcaemic secondary hyperparathyroidism.
Farnebo F; Farnebo LO; Nordenström J; Larsson C
Eur J Surg; 1997 May; 163(5):331-7. PubMed ID: 9195165
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological peculiarities in parathyroid disease with hypercalcaemic crisis.
Bondeson AG; Bondeson L; Thompson NW
Eur J Surg; 1993; 159(11-12):613-7. PubMed ID: 8130303
[TBL] [Abstract][Full Text] [Related]
3. Rare somatic inactivation of the multiple endocrine neoplasia type 1 gene in secondary hyperparathyroidism of uremia.
Tahara H; Imanishi Y; Yamada T; Tsujimoto Y; Tabata T; Inoue T; Inaba M; Morii H; Nishizawa Y
J Clin Endocrinol Metab; 2000 Nov; 85(11):4113-7. PubMed ID: 11095441
[TBL] [Abstract][Full Text] [Related]
4. Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11.
Falchetti A; Bale AE; Amorosi A; Bordi C; Cicchi P; Bandini S; Marx SJ; Brandi ML
J Clin Endocrinol Metab; 1993 Jan; 76(1):139-44. PubMed ID: 8421078
[TBL] [Abstract][Full Text] [Related]
5. Somatic mutation of the MEN1 gene in parathyroid tumours.
Heppner C; Kester MB; Agarwal SK; Debelenko LV; Emmert-Buck MR; Guru SC; Manickam P; Olufemi SE; Skarulis MC; Doppman JL; Alexander RH; Kim YS; Saggar SK; Lubensky IA; Zhuang Z; Liotta LA; Chandrasekharappa SC; Collins FS; Spiegel AM; Burns AL; Marx SJ
Nat Genet; 1997 Aug; 16(4):375-8. PubMed ID: 9241276
[TBL] [Abstract][Full Text] [Related]
6. Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumours.
Bergman L; Boothroyd C; Palmer J; Grimmond S; Walters M; Teh B; Shepherd J; Hartley L; Hayward N
Br J Cancer; 2000 Oct; 83(8):1003-8. PubMed ID: 10993646
[TBL] [Abstract][Full Text] [Related]
7. Allelic loss from chromosome 11 in parathyroid tumors.
Friedman E; De Marco L; Gejman PV; Norton JA; Bale AE; Aurbach GD; Spiegel AM; Marx SJ
Cancer Res; 1992 Dec; 52(24):6804-9. PubMed ID: 1360870
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity of markers on chromosome 11 in tumors from patients with multiple endocrine neoplasia syndrome type 1.
Radford DM; Ashley SW; Wells SA; Gerhard DS
Cancer Res; 1990 Oct; 50(20):6529-33. PubMed ID: 1976436
[TBL] [Abstract][Full Text] [Related]
9. Phosphatemia is related to chromosomal aberrations of parathyroid glands in patients with hyperparathyroidism.
Chudek J; Nagy A; Kokot F; Podwinski A; Wiecek A; Ritz E; Kovacs G
J Nephrol; 2007; 20(2):164-72. PubMed ID: 17514620
[TBL] [Abstract][Full Text] [Related]
10. Clonal analysis by chromosome 11 microsatellite-PCR of microdissected parathyroid tumors from MEN 1 patients.
Morelli A; Falchetti A; Amorosi A; Tonelli F; Bearzi I; Ranaldi R; Tomassetti P; Brandi ML
Biochem Biophys Res Commun; 1996 Oct; 227(3):736-42. PubMed ID: 8886003
[TBL] [Abstract][Full Text] [Related]
11. Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations.
Thakker RV; Pook MA; Wooding C; Boscaro M; Scanarini M; Clayton RN
J Clin Invest; 1993 Jun; 91(6):2815-21. PubMed ID: 8514889
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism.
Libutti SK; Crabtree JS; Lorang D; Burns AL; Mazzanti C; Hewitt SM; O'Connor S; Ward JM; Emmert-Buck MR; Remaley A; Miller M; Turner E; Alexander HR; Arnold A; Marx SJ; Collins FS; Spiegel AM
Cancer Res; 2003 Nov; 63(22):8022-8. PubMed ID: 14633735
[TBL] [Abstract][Full Text] [Related]
13. Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases.
Valdes N; Alvarez V; Diaz-Cadorniga F; Aller J; Villazon F; Garcia I; Herrero A; Coto E
Anticancer Res; 1998; 18(4A):2685-9. PubMed ID: 9703929
[TBL] [Abstract][Full Text] [Related]
14. Morphology, DNA ploidy and allele losses on chromosome 11 in sporadic hyperparathyroidism and that associated with multiple neoplasia, type 1.
Sandelin K; Larsson C; Falkmer UG; Farnebo LO; Grimelius L; Nordenskjöld M
Eur J Surg; 1992 Apr; 158(4):199-206. PubMed ID: 1352132
[TBL] [Abstract][Full Text] [Related]
15. [Chromosome abnormalities in hyperparathyroidism: utility of comparative genomic hybridization in the study of parathyroid hyperplasias].
Afonso S; Cigudosa JC; Santamaría I; Otero A; Menárguez J; García Miranda JL
Nefrologia; 2003; 23 Suppl 2():2-6. PubMed ID: 12778845
[TBL] [Abstract][Full Text] [Related]
16. Novel 14 base-pair deletion of the MEN1 gene in a patient with recurrent primary hyperparathyroidism.
Katai M; Sakurai A; Uchino S; Minemura K; Hashizume K; Fukushima Y
Jpn J Clin Oncol; 2006 Jun; 36(6):395-7. PubMed ID: 16714299
[TBL] [Abstract][Full Text] [Related]
17. Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours.
Farrell WE; Simpson DJ; Bicknell J; Magnay JL; Kyrodimou E; Thakker RV; Clayton RN
Br J Cancer; 1999 Apr; 80(1-2):44-50. PubMed ID: 10389976
[TBL] [Abstract][Full Text] [Related]
18. Genetic abnormalities in parathyroid nodules of uremic patients.
Chudek J; Ritz E; Kovacs G
Clin Cancer Res; 1998 Jan; 4(1):211-4. PubMed ID: 9516973
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic and molecular analyses of multiple endocrine neoplasias of the MEN1 syndrome.
Pourani J; Kaserer K; Pfragner R
Int J Oncol; 2002 May; 20(5):971-6. PubMed ID: 11956591
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid glands in uraemic patients with refractory hyperparathyroidism: histopathology and p53 protein expression analysis.
Martin LN; Kayath MJ; Vieira JG; Nosé-Alberti V
Histopathology; 1998 Jul; 33(1):46-51. PubMed ID: 9726048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
